Compare LEGN & WH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEGN | WH |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.7B |
| IPO Year | 2020 | N/A |
| Metric | LEGN | WH |
|---|---|---|
| Price | $17.18 | $78.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $63.46 | ★ $92.92 |
| AVG Volume (30 Days) | ★ 3.1M | 1.4M |
| Earning Date | 03-10-2026 | 02-18-2026 |
| Dividend Yield | N/A | ★ 2.12% |
| EPS Growth | N/A | ★ 38.00 |
| EPS | N/A | ★ 4.33 |
| Revenue | $909,045,000.00 | ★ $1,436,000,000.00 |
| Revenue This Year | $67.56 | $5.20 |
| Revenue Next Year | $45.77 | $5.82 |
| P/E Ratio | ★ N/A | $17.84 |
| Revenue Growth | ★ 74.75 | 3.83 |
| 52 Week Low | $16.24 | $69.21 |
| 52 Week High | $45.30 | $113.07 |
| Indicator | LEGN | WH |
|---|---|---|
| Relative Strength Index (RSI) | 31.66 | 56.68 |
| Support Level | $16.24 | $71.64 |
| Resistance Level | $17.38 | $81.19 |
| Average True Range (ATR) | 0.88 | 2.38 |
| MACD | -0.06 | 0.13 |
| Stochastic Oscillator | 17.33 | 72.81 |
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
As of June 30, 2025, Wyndham Hotels & Resorts operates 846,700 rooms across more than 20 brands predominantly in the economy and midscale segments. Super 8 is the largest brand, representing around 18% of all rooms, with Days Inn (13%) and Ramada (14%) the next two largest brands, as of the end of 2024. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represents 56% of total rooms, as of the end of 2024.